Literature DB >> 77661

Management of malignant esophagorespiratory fistula.

D M Lolley, J F Ray, H T Ransdell, M A Razzuk, H C Urschel.   

Abstract

Esophagorespiratory communication developed in 46 patients among 570 with esophageal cancer. Therapy was basically palliative and aimed at mechanical interruption of the fistula, restoration of esophageal continuity, and avoidance of external tubes and appliances. Supportive therapy, gastrostomy, tracheostomy, and esophageal exclusion and diversion procedures resulted in little prolongation of life and poor palliation of the patient. Permanent endoesophageal intubation with tubes of the Celestin variety resulted in best palliation with minimal operative risk for most terminal patients. Colon bypass and occasional resection can accomplish the same goal and possibly provide long-term survival in good-risk, young patients with small tumors.

Entities:  

Mesh:

Year:  1978        PMID: 77661     DOI: 10.1016/s0003-4975(10)63600-4

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  Hypercalcemia, pneumothorax and pneumoperitoneum in a patient with pulmonary mycobacteriosis and esophageal carcinoma.

Authors:  A Baydur; U Slager; V M Anderson
Journal:  West J Med       Date:  1980-07

2.  Characteristics of esophagorespiratory fistulas resulting from esophageal cancers: a single-center study on 243 cases in a 20-year period.

Authors:  Akos Balazs; Zoltan Galambos; Peter K Kupcsulik
Journal:  World J Surg       Date:  2009-05       Impact factor: 3.352

3.  Resection of the carina and oesophagus for malignant tumours of the oesophagus or tracheobronchial tree.

Authors:  T Ikeda; T Sakai; S Sakai; S Kaseda; R Obitsu; M Iwatsuka
Journal:  Thorax       Date:  1984-03       Impact factor: 9.139

4.  Comparative study of esophageal stent and feeding gastrostomy/jejunostomy for tracheoesophageal fistula caused by esophageal squamous cell carcinoma.

Authors:  Yen-Hao Chen; Shau-Hsuan Li; Yi-Chun Chiu; Hung-I Lu; Cheng-Hua Huang; Kun-Ming Rau; Chien-Ting Liu
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.